Why Are We Still Talking about Ivermectin? Editorial Note on Stone et al. Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment

Ivermectin treatment of loiasis.

Why should we still care about oncogenes?

Although oncogenes and their transformation mechanisms have been known for 30 years, we are just now using our understanding of protein function to abrogate the activity of these genes to block cancer growth. The advent of specific small-molecule inhibitors has been a tremendous step in the fight against cancer and their main targets are the cellular counterparts of viral oncogenes. The best-kn...

Health System Resilience: What Are We Talking About? A Scoping Review Mapping Characteristics and Keywords

Background Health systems are based on 6 functions that need to work together at all times to effectively deliver safe and quality health services. These functions are vulnerable to shocks and changes; if a health system is unable to withstand the pressure from a shock, it may cease to function or collapse. The concept of resilience has been introduced with the goal of strengthening healt...

Whose Art Are We Talking About?

Jeannette Pols and Tamar Sharon kindly reviewed my case study of the art of living with technology as an engagement with technomoral change. I am indebted to them for their careful reading and critical suggestions to further elaborate the project. In my response I focus on the question whose art we are talking about, while further elucidating the reflexivity addressed in my essay. I conclude wi...

"Sudden death"--what are we talking about?